未登录

J

Jay T. Evans

university of montana system

H指数:27

被引数:3,108

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Covalent conjugation of a TLR7/8 agonist to recombinant influenza A virus hemagglutinin provides enhanced immunogenicity and protection against disease from a drifted strain

JOURNAL OF IMMUNOLOGY

IF3.4

2025-11-010

PRE

Mincle receptor agonist UM-1098 and TLR4 agonist INI-2002 combination adjuvant enhances Th1 responses and provides protection against Mycobacterium tuberculosis challenge in mice

Mincle受体激动剂UM-1098与TLR4激动剂INI-2002组合佐剂可增强Th1反应，并使小鼠在分枝杆菌结核分枝杆菌（Mycobacterium tuberculosis）攻击中受到保护。

IF2.2

2025-08-070

OAAI

Encapsulation of the lipidated TLR7/8 agonist INI-4001 into ionic liposomes impacts H7 influenza antigen-specific immune responses

将脂质化的TLR7/8激动剂INI-4001封装到离子脂质体中会影响H7流感抗原特异性免疫应答

Drug Delivery and Translational Research

IF5.5

2025-07-140

OAAI

Intranasal administration of a synthetic TLR4 agonist INI-2004 significantly reduces allergy symptoms following therapeutic administration in a murine model of allergic sensitization

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-07-231

OAAI

Vaccination with Mincle agonist UM-1098 and mycobacterial antigens induces protective Th1 and Th17 responses

IF6.5

2024-06-066

OAAI

Adjuvanted Vaccine Induces Functional Antibodies against Pseudomonas aeruginosa Filamentous Bacteriophages

IF3.4

2024-01-240

OAAI

Co-Delivery of a Novel Lipidated TLR7/8 Agonist and Hemagglutinin-Based Influenza Antigen Using Silica Nanoparticles Promotes Enhanced Immune Responses

IF5.5

2024-01-133

OAAI

Co-Delivery of Novel Synthetic TLR4 and TLR7/8 Ligands Adsorbed to Aluminum Salts Promotes Th1-Mediated Immunity against Poorly Immunogenic SARS-CoV-2 RBD

IF3.4

2023-12-232

OAAI

Diamino Allose Phosphates: Novel, Potent, and Highly Stable Toll-like Receptor 4 Agonists

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2023-10-173

PRE

Self-Adjuvanting TLR7/8 Agonist and Fentanyl Hapten Co-Conjugate Achieves Enhanced Protection against Fentanyl Challenge

BIOCONJUGATE CHEMISTRY

IF3.9

2023-09-278

OAAI

A TLR7/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models

IF6.5

2023-07-249

OAAI

A lipidated TLR7/8 adjuvant enhances the efficacy of a vaccine against fentanyl in mice

IF6.5

2023-07-106

OAAI

Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination

SCIENTIFIC REPORTS

IF3.9

2022-10-1814

OAAI

Using Dual Toll-like Receptor Agonism to Drive Th1-Biased Response in a Squalene- and α-Tocopherol-Containing Emulsion for a More Effective SARS-CoV-2 Vaccine

IF5.5

2022-07-125

OAAI

Adjuvanted multivalent vaccine targeting clinically relevant Pf bacteriophage creates cross-reactive antibodies

JOURNAL OF IMMUNOLOGY

IF3.4

2022-05-010

PRE

Intranasal administration of a novel synthetic TLR4 agonist suppresses allergen-specific Th2 responses in mice

JOURNAL OF IMMUNOLOGY

IF3.4

2022-05-010

PRE

Pre-treatment with a novel synthetic TLR4 agonist prior to challenge with mouse-adapted H1N1. and H2N3 influenza strains reduced morbidity and mortality in BALB/c mice

JOURNAL OF IMMUNOLOGY

IF3.4

2022-05-010

PRE

Cationic Liposomes containing a TLR4 agonist promote the efficient development of cellular immunity against SARS-CoV-2 Spike protein in a subunit vaccine

JOURNAL OF IMMUNOLOGY

IF3.4

2022-05-011

PRE

Precision Vaccines: Lessons Learned From the Coronavirus Pandemic

CLINICAL INFECTIOUS DISEASES

IF7.3

2022-04-190

OAAI

Advancing Adjuvants for Mycobacterium tuberculosis Therapeutics

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-10-2515

OAAI